EICHOR
● Completed
Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
Condition: Dyskinesia · Cerebral Palsy · Sponsor: Neurocrine Biosciences
About this study
The primary objective of this study is to evaluate the efficacy of valbenazine versus placebo on improving chorea in pediatric and adult participants who have dyskinesia due to cerebral palsy (DCP) with choreiform movements.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (38)
| Neurocrine Clinical Site | San Diego, California, United States | — |
| Neurocrine Clinical Site | Aurora, Colorado, United States | — |
| Neurocrine Clinical Site | Stamford, Connecticut, United States | — |
| Neurocrine Clinical Site | Gulf Breeze, Florida, United States | — |
| Neurocrine Clinical Site | Miami, Florida, United States | — |
| Neurocrine Clinical Site | Orlando, Florida, United States | — |
| Neurocrine Clinical Site | Chicago, Illinois, United States | — |
| Neurocrine Clinical Site | Baltimore, Maryland, United States | — |
| Neurocrine Clinical Site | Boston, Massachusetts, United States | — |
| Neurocrine Clinical Site | Farmington Hills, Michigan, United States | — |
| Neurocrine Clinical Site | Saint Paul, Minnesota, United States | — |
| Neurocrine Clinical Site | New York, New York, United States | — |
+ 26 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05206513